[go: up one dir, main page]

MX2018006381A - Composiciones de aceite de cannabis y metodos para preparacion de las mismas. - Google Patents

Composiciones de aceite de cannabis y metodos para preparacion de las mismas.

Info

Publication number
MX2018006381A
MX2018006381A MX2018006381A MX2018006381A MX2018006381A MX 2018006381 A MX2018006381 A MX 2018006381A MX 2018006381 A MX2018006381 A MX 2018006381A MX 2018006381 A MX2018006381 A MX 2018006381A MX 2018006381 A MX2018006381 A MX 2018006381A
Authority
MX
Mexico
Prior art keywords
cannabis oil
oil compositions
produce
methods
cannabis
Prior art date
Application number
MX2018006381A
Other languages
English (en)
Other versions
MX385238B (es
Inventor
Finley Constance
Poole Bestwick Haley
Original Assignee
Constance Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Constance Therapeutics Inc filed Critical Constance Therapeutics Inc
Publication of MX2018006381A publication Critical patent/MX2018006381A/es
Publication of MX385238B publication Critical patent/MX385238B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención proporciona composiciones de aceite de cannabis, que incluyen composiciones de aceite de cannabis que contienen vitamina E, y métodos para preparar las composiciones de aceite de cannabis. En algunas realizaciones, la invención proporciona un método para preparar una composición de aceite de cannabis que comprende eluir cannabinoides del material vegetal de cannabis con un disolvente para producir un eluato; filtrar el eluato con un filtro para producir un filtrado; evaporar el disolvente del filtrado con un destilador para producir un destilado; y purgar el destilado en condiciones suficientes para eliminar el disolvente residual. En algunas realizaciones, el método incluye además mezclar una cantidad de vitamina E con el extracto. También se describen composiciones de aceite de cannabis mezclado que contienen mezclas de preparaciones de aceite de cannabis.
MX2018006381A 2015-11-24 2016-11-23 Composiciones de aceite de cannabis y metodos para preparacion de las mismas. MX385238B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562259549P 2015-11-24 2015-11-24
PCT/US2016/063662 WO2017091764A1 (en) 2015-11-24 2016-11-23 Cannabis oil compositions and methods for preparation thereof

Publications (2)

Publication Number Publication Date
MX2018006381A true MX2018006381A (es) 2019-02-14
MX385238B MX385238B (es) 2025-03-14

Family

ID=58763660

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018006381A MX385238B (es) 2015-11-24 2016-11-23 Composiciones de aceite de cannabis y metodos para preparacion de las mismas.

Country Status (8)

Country Link
US (3) US10806707B2 (es)
EP (1) EP3380096A4 (es)
AU (1) AU2016359160A1 (es)
CA (1) CA3006182A1 (es)
CO (1) CO2018006452A2 (es)
IL (2) IL299047A (es)
MX (1) MX385238B (es)
WO (1) WO2017091764A1 (es)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10188086B2 (en) * 2016-08-21 2019-01-29 Daniel Michael Leo Insect production systems and methods
EP3250200A4 (en) * 2015-01-31 2018-09-19 Constance Therapeutics, Inc. Methods for preparation of cannabis oil extracts and compositions
US10035081B2 (en) * 2016-04-14 2018-07-31 Capna Intellectual, Inc. Methods to reduce chlorophyll co-extraction through extraction of select moieties essential oils and aromatic isolates
CN109789124A (zh) * 2016-08-03 2019-05-21 塞尔达治疗手术有限公司 大麻属组合物
US10264768B2 (en) * 2016-08-21 2019-04-23 Daniel Michael Leo Insect production systems and methods
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US10716819B2 (en) * 2017-02-22 2020-07-21 Yabuwi, Inc. Food grade cannabis extracts and methods for their preparation
US20240008419A1 (en) * 2017-05-31 2024-01-11 Insectergy, Llc Cannabis farming systems and methods
CA3103178A1 (en) * 2017-06-27 2019-01-03 Enviro BioMedical Laboratories Inc. Blended cannabis compounds and methods of making the same
CA3029528C (en) * 2017-09-08 2020-06-30 Zohar KOREN Compositions comprising a cannabinoid and spilanthol
IT201700106078A1 (it) * 2017-09-22 2019-03-22 Meschiari Guido Composizione farmaceutica a base di cannabinoidi.
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
BR112020017023A2 (pt) * 2018-02-23 2021-03-02 Nicola Michael Spirtos terapêutica à base de cannabis e método de uso
SG11202010006UA (en) * 2018-04-09 2020-11-27 Ellevet Sciences Hemp extract for treatment of pain in animals
CN110554100B (zh) * 2018-06-01 2021-06-22 江苏康缘药业股份有限公司 一种杏贝止咳颗粒指纹图谱建立及其成分检测方法
JP2021527132A (ja) * 2018-06-15 2021-10-11 キャンパル アニマル セラピューティクス リミテッド カンナビノイド組成物及びそれを使用した治療法
WO2020021544A1 (en) * 2018-07-25 2020-01-30 Bol Pharma Ltd. Cannabidiol and methylthio-butyl-isothiocyanate for treating inflammatory diseases
CN108815280A (zh) * 2018-08-09 2018-11-16 集美大学 一种用于治疗石斑鱼变形假单胞菌病的中药组合物及其制备方法和应用
CN108635446A (zh) * 2018-08-09 2018-10-12 集美大学 一种利用中西药联用治疗石斑鱼变形假单胞菌病的组合物及其制备方法和应用
US10669248B2 (en) 2018-08-10 2020-06-02 Natural Extraction Systems, LLC Methods to chemically modify cannabinoids
US12420214B2 (en) 2018-08-10 2025-09-23 Natural Extraction Systems, LLC Methods to produce products comprising cannabinoids
WO2020037133A1 (en) * 2018-08-17 2020-02-20 Shepard Kirsten K Cannabidiol composition and methods thereof
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
JP6536733B1 (ja) * 2018-10-29 2019-07-03 不二製油株式会社 アーモンド風味油脂の製造法
EP3880184A4 (en) * 2018-11-13 2022-09-28 Hexo Operations Inc. Method of manufacturing vape oil including a cannabinoid for use in a vape device
CN109431830B (zh) * 2018-12-18 2021-07-27 陈东升 一种抗氧化的天然组合物、食品、化妆品、保健品和药物
EP3902553A4 (en) * 2018-12-27 2022-10-05 Buzzelet Development And Technologies Ltd ENRICHED CANNABINOID COMPOSITION IN HERBAL PREPARATION AND METHOD OF TREATMENT
AU2019413789B2 (en) * 2018-12-29 2025-05-29 Buzzelet Development And Technologies Ltd. Isolated or synthetic cannabinoid compositions with selected terpene blend and methods of use thereof
CA3139308A1 (en) * 2019-05-06 2020-11-12 Atomic Health, Inc. Systems and methods for manufacturing cannabis edibles, and resulting edible products
SG11202110779SA (en) 2019-05-06 2021-10-28 Univ British Columbia Antibiotic cannabinoid-terpene formulations
WO2020255133A1 (en) * 2019-06-18 2020-12-24 The Cures Ltd. Novel therapeutic preparations comprising scutellaria barbata
US11622956B1 (en) * 2019-06-26 2023-04-11 RCR BioPharma Compound and method for treating diseases and disorders
EP3999088B1 (en) 2019-07-15 2024-07-03 The Procter & Gamble Company Topical skincare compositions comprising centella asiatica
EP3946262B1 (en) * 2019-08-30 2024-07-31 Evie Sa Loaded granules, their process of production and their uses
WO2021046196A1 (en) * 2019-09-06 2021-03-11 Quicksilver Scientific, Inc. Microemulsion delivery systems for cannabis extracts and terpenes
WO2021050429A1 (en) * 2019-09-10 2021-03-18 Pureform Global, Inc. Topical composition for treatment of pain
US11021675B2 (en) * 2019-09-13 2021-06-01 Thar Process, Inc. Process for producing refined oils from botanical plant matter using a supercritical fluid
US11826673B2 (en) * 2019-10-25 2023-11-28 Chimera Technology LLC Solvent-less extraction of cannabinoid acids
US10946306B1 (en) * 2019-11-27 2021-03-16 World Class Extractions Inc. Solvent-based extraction methods
EP4087592A1 (en) * 2020-01-10 2022-11-16 Real Isolates, LLC Methods for obtaining compounds from a plant or fungus material, respective compositions, and uses thereof
CN111171127B (zh) * 2020-02-26 2021-07-30 浙江省农业科学院 紫云英lhy基因及其应用
WO2021188295A1 (en) * 2020-03-17 2021-09-23 Epidarus Therapeutics, Llc Compositions for inhibiting degradation of hyaluronic acid and methods of use thereof
WO2021191888A1 (en) * 2020-03-26 2021-09-30 I.P. Israel Patents Ltd. Cannabis sativa (hemp and cannabis) products for viral disease prevention and management
US11583574B2 (en) 2020-04-02 2023-02-21 Mitchell Lynn Tate Treatement of pathogen infections formulations and methods for use
CN115605289A (zh) * 2020-04-29 2023-01-13 利加尔有限合伙公司（Nz） 印迹聚合物及其使用方法
US20230201157A1 (en) * 2020-05-24 2023-06-29 Asana Bio Group Ltd. Compositions of cannabinoids and methods of using same
EP4185131A1 (en) * 2020-07-21 2023-05-31 AI Pharmaceuticals Jamaica Limited Compositions and methods for treatment of cancers
WO2022067078A1 (en) * 2020-09-25 2022-03-31 Mdm Enterprise Solutions Inc. Precision cannabinoid therapy formulations and methods of use
WO2022091050A1 (en) * 2020-10-31 2022-05-05 Ai Pharmaceuticals Jamaica Limited Compositions for treatment of interstitial cystitis and other bladder disease
US20220226241A1 (en) * 2021-01-20 2022-07-21 Therabody, Inc. Stable organic cannabinoid oil blend formulations
US20240091292A1 (en) * 2021-02-01 2024-03-21 Apollon Formularies Plc Methods for treatment of human cancers using cannabis compositions
CN113070484A (zh) * 2021-03-10 2021-07-06 海南华创槟榔研究院 一种尺寸可控球形纳米银粒子、制备方法及应用
US11633425B2 (en) 2021-05-13 2023-04-25 Ahava—Dead Sea Laboratories Ltd. Anti-glycation compositions
WO2023004160A1 (en) * 2021-07-23 2023-01-26 Ojai Energetics Pbc Methods and compositions for microencapsulated compounds
CN113577076B (zh) * 2021-08-11 2023-08-18 湖南农业大学 一种钩吻素子在制备治疗急性肺损伤药物中的应用
AU2021107253A4 (en) * 2021-08-24 2021-12-09 Cymra Life Sciences Limited A composition and uses thereof
IT202100028997A1 (it) * 2021-11-16 2023-05-16 C I A M S R L Composizioni utili per ridurre il declino cognitivo in animali da compagnia
US12440454B2 (en) 2022-02-01 2025-10-14 Portland Technology Holdings Llc Pharmaceutical compositions containing hemp extract for administration to felines and related methods
EP4486303A1 (en) * 2022-03-04 2025-01-08 Pinata Holdings Inc. Enteric coated dry powdered cannabinoid formulations
US11911427B2 (en) 2022-03-12 2024-02-27 Wilhelm Rumpf Extraction and infusion of active components from plant materials
BE1030549B1 (fr) * 2022-05-23 2023-12-18 Laboratoire Puressentiel S A Complément alimentaire
CN114766679B (zh) * 2022-06-22 2022-08-30 北京中科生仪科技有限公司 一种美白、抗氧化组合物及其制剂、制备工艺与应用
GB202210304D0 (en) * 2022-07-13 2022-08-24 Hytn Group Ltd Composition comprising cannabidiol
CN115337239B (zh) * 2022-08-31 2023-08-18 广州研智化妆品有限公司 一种具有舒缓及修复功效的精华油及其制备方法
US20240299464A1 (en) * 2023-02-15 2024-09-12 Minh H. Nguyen Botanical compounds, methods, and procedures for medicinal treatment related to immunoinflammation, neuroinflammation, depression, memory, focus, and nerve degeneration
WO2024173433A2 (en) * 2023-02-16 2024-08-22 Infinitum Health, Llc Methods of relieving pain

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716928A (en) * 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
GB9726916D0 (en) 1997-12-19 1998-02-18 Danbiosyst Uk Nasal formulation
US6082370A (en) 1998-02-09 2000-07-04 Rousseau Research, Inc. Cigarette with dry powered Vitamin E
US6797507B2 (en) 2000-03-03 2004-09-28 George E. Hahn Methods of using worm castings for fungal control
GB2377218A (en) 2001-05-04 2003-01-08 Gw Pharmaceuticals Ltd Process and apparatus for extraction of active substances and enriched extracts from natural products
US20030134018A1 (en) 2001-12-31 2003-07-17 Cargill, Inc. Process for oil extraction
GB2384184B (en) 2002-01-10 2005-01-12 Aea Technology Plc Cannabis aerosol
EP1482917B1 (en) 2002-02-01 2019-05-08 GW Pharma Limited Compositions comprising cannabidiolic acid for treatment of nausea, vomiting, emesis, motion sickness or like conditions
US7344736B2 (en) 2002-08-14 2008-03-18 Gw Pharma Limited Extraction of pharmaceutically active components from plant materials
GB2418612A (en) 2004-10-01 2006-04-05 Gw Pharma Ltd Inhibition of tumour cell migration with cannabinoids
GB2439393B (en) * 2006-06-23 2011-05-11 Gw Pharma Ltd Cannabinoids for use in the treatment of neuropathic pain
GB2448535A (en) 2007-04-19 2008-10-22 Gw Pharma Ltd New use for cannabinoid-containing plant extracts
US20090130220A1 (en) 2007-11-20 2009-05-21 Johnson Pamela A Cosmetic composition having pomace olive oil
GB2460672B (en) 2008-06-04 2012-01-04 Gw Pharma Ltd Cannabinoids in combination with non-cannabinoid chemotherapeutic agents that are alkylating agents
GB2471987B (en) 2008-06-04 2012-02-22 Gw Pharma Ltd Anti-tumoural effects of cannabinoid combinations
EP2201942A1 (de) 2008-12-23 2010-06-30 Intendis GmbH Zusammensetzung mit Hanföl für die Behandlung topischer Erkrankungen
GB2471523A (en) 2009-07-03 2011-01-05 Gw Pharma Ltd Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
GB2478595B (en) 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
TWI583374B (zh) 2010-03-30 2017-05-21 Ｇｗ伐瑪有限公司 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
US8445034B1 (en) 2010-11-02 2013-05-21 Albert L Coles, Jr. Systems and methods for producing organic cannabis tincture
EP2642982A2 (en) 2010-11-22 2013-10-02 Johnson Matthey Public Limited Company Stable cannabinoid compositions and methods for making and storing them
GB2494461A (en) 2011-09-12 2013-03-13 Gw Pharma Ltd Phytocannabinoids for use in the treatment of invasive cancers or metastases
GB2495118B (en) 2011-09-29 2016-05-18 Otsuka Pharma Co Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
ITMI20111806A1 (it) 2011-10-05 2013-04-06 Freia Farmaceutici S R L Composizione per il trattamento delle lesioni cutanee
GB201117956D0 (en) 2011-10-18 2011-11-30 Otsuka Pharma Co Ltd Phytocannabinoids for use in the treatment of breast cancer
GB201119198D0 (en) 2011-11-07 2011-12-21 Jack Amanda Removal of surgical casts
SI2844243T1 (sl) 2012-05-03 2020-02-28 Echo Pharmaceuticals B.V. Metoda za pripravo izolata iz rastline konoplje, ki obsega delta-9-tetrahidrokanabinol
CN102742840B (zh) * 2012-07-16 2013-10-23 西藏然康科技有限公司 一种玛卡虫草口含片及其制备方法
CN103005427B (zh) 2012-11-23 2013-11-27 浙江华立生命科技有限公司 改进的含火麻仁油的保健品组合物及其制备方法
US10792318B2 (en) 2013-03-14 2020-10-06 Sc Laboratories, Inc. Bioactive concentrates and uses thereof
US9199960B2 (en) 2013-05-02 2015-12-01 Frederick R. Ferri Method and apparatus for processing herbaceous plant materials including the cannabis plant
US20150057342A1 (en) * 2013-08-21 2015-02-26 Cannabics Pharmaceuticals Inc Compositions for combined immediate and sustained release of cannabinoids, methods of manufacture and use thereof
US9808249B2 (en) 2013-08-23 2017-11-07 Ethicon Llc Attachment portions for surgical instrument assemblies
US10106760B2 (en) 2013-10-14 2018-10-23 Jayson Emo Organic based extraction system
US9333229B2 (en) 2013-10-16 2016-05-10 William Bjorncrantz Winterized crude cannabis extracts and methods of preparation and use
CA2925018A1 (en) * 2013-11-15 2015-05-21 Jj 206, Llc Systems and methods for a vaporization device and product usage control and documentation
US8906429B1 (en) 2013-12-11 2014-12-09 Jeffrey A. Kolsky Medical cannabis lozenges and compositions thereof
US9597279B2 (en) 2014-02-28 2017-03-21 HDDC Holdings, LLC Anti-aging dermal composition comprising herbal extracts
US9186386B2 (en) 2014-04-17 2015-11-17 Gary J. Speier Pharmaceutical composition and method of manufacturing
CN104304815A (zh) 2014-11-11 2015-01-28 广西壮族自治区水牛研究所 一种能提高水牛抗氧化机能的饲粮

Also Published As

Publication number Publication date
US20240285549A1 (en) 2024-08-29
EP3380096A4 (en) 2019-10-23
US10806707B2 (en) 2020-10-20
EP3380096A1 (en) 2018-10-03
IL299047A (en) 2023-02-01
IL259571A (en) 2018-07-31
CO2018006452A2 (es) 2018-08-31
WO2017091764A1 (en) 2017-06-01
US20210275465A1 (en) 2021-09-09
CA3006182A1 (en) 2017-06-01
US20180344661A1 (en) 2018-12-06
MX385238B (es) 2025-03-14
AU2016359160A1 (en) 2018-06-14

Similar Documents

Publication Publication Date Title
CO2018006452A2 (es) Composiciones de aceite de cannabis y métodos para preparación de las mismas
MX386351B (es) Métodos para la preparación de extractos y composiciones de aceite de cannabis.
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
CO2019002371A2 (es) Adenovirus armado con captador biespecífico de linfocitos t (bite)
IN2014DN09507A (es)
MX378481B (es) Composiciones cosmeticas que comprenden e/z-bencilideno-5,6-dimetoxi-3,3-dimetilindan-1-ona.
NZ731248A (en) Cannabis extracts and methods of preparing and using same
PE20211694A1 (es) Metodos de purificacion de cannabinoides, composiciones y kits de los mismos
ECSP17037217A (es) Modificación de lípidos de plantas con contenido de pufas
BR112016028476A8 (pt) compostos, composição, uso de um composto e método para o combate dos fungos nocivos
MX2017004896A (es) Uso de hexadeca-8, 15-dienal como producto quimico aromatico.
MX2020001443A (es) Sistema y métodos de extracción fitoquímica para extraer fitoquímicos de plantas incluidas las plantas de la familia cannabaceae sensu stricto.
CL2019000198A1 (es) Nuevas formulaciones y composiciones de cannabis en comprimidos y métodos para su elaboración.
UY36696A (es) Un método y un aparato para formar una fracción de lignina, una composición de lignina y su uso
EA202091184A1 (ru) Композиции, содержащие тимогидрохинон, и способ их получения
CL2016000148A1 (es) Nuevos compuestos isoindolina o isoquinolina, un proceso para su preparación y composiciones farmacéuticas que los contienen.
CO2021001057A2 (es) Composición y método para el ahorro de opioides
MX383767B (es) Método para obtener una biomasa de una microalga de la especie tetraselmis chuii enriquecida en superóxido dismutasa (sod).
IL232696B (en) Compound and method for detecting molecules of interest
CO2019003424A2 (es) Extracto de planta impregnado de alulosa y método de preparación para el mismo
CR20180181A (es) Nuevos derivados de imidazol[4,5-b]piridina, un proceso para su preparación y composiciones farmacéuticas que los contienen
CO2017003798A2 (es) Método de tratamiento para antibrote de tubérculos con cantidad reducida de cipc
RU2017121910A (ru) Биологически активная композиция из томатов, имеющая уменьшенное содержание ликопина
MX373305B (es) Método para estabilizar una composición que contiene al menos un producto de deshidratación interna de un azúcar hidrogenado, composición resultante y usos de esta.
MX2018008069A (es) Composicion lipida vegetal para promover el crecimiento del cabello, metodo para promover el crecimiento del cabello y uso de los lipidos vegetales.